These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study. Kim SH; Suh Y; Ah YM; Jun K; Lee JY Support Care Cancer; 2020 Aug; 28(8):3617-3626. PubMed ID: 31802250 [TBL] [Abstract][Full Text] [Related]
3. Drug interactions between chemotherapeutic regimens and antiepileptics. Yap KY; Chui WK; Chan A Clin Ther; 2008 Aug; 30(8):1385-407. PubMed ID: 18803983 [TBL] [Abstract][Full Text] [Related]
4. [Novel oral anticancer drugs: a review of adverse drug reactions, interactions and patient adherence]. Bartal A; Mátrai Z; Szucs A; Belinszkaja G; Langmár Z; Rosta A Orv Hetil; 2012 Jan; 153(2):66-78. PubMed ID: 22217686 [TBL] [Abstract][Full Text] [Related]
5. Electronic database to detect drug-drug interactions between antidepressants and oral anticancer drugs from a cancer center in Singapore: implications to clinicians. Chan A; Yap KY; Koh D; Low XH; Cheung YT; Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):939-47. PubMed ID: 21732473 [TBL] [Abstract][Full Text] [Related]
6. Harnessing the internet cloud for managing drug interactions with chemotherapy regimens in patients with cancer suffering from depression. Yap KY; Ho YX; Chui WK; Chan A Acta Oncol; 2010 Nov; 49(8):1235-45. PubMed ID: 20515422 [TBL] [Abstract][Full Text] [Related]
7. Drug-drug interactions in pediatric oncology patients. Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376 [TBL] [Abstract][Full Text] [Related]
8. Clinically relevant drug interactions between anticancer drugs and psychotropic agents. Yap KY; Tay WL; Chui WK; Chan A Eur J Cancer Care (Engl); 2011 Jan; 20(1):6-32. PubMed ID: 20030690 [TBL] [Abstract][Full Text] [Related]
9. Drug Interactions in the Treatment of Malignancy in HIV-Infected Patients. Welz T; Wyen C; Hensel M Oncol Res Treat; 2017; 40(3):120-127. PubMed ID: 28253501 [TBL] [Abstract][Full Text] [Related]
10. CYP3A4-mediated pharmacokinetic interactions in cancer therapy. Tian D; Hu Z Curr Drug Metab; 2014; 15(8):808-17. PubMed ID: 25705904 [TBL] [Abstract][Full Text] [Related]
11. Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance. Ramos-Esquivel A; Víquez-Jaikel Á; Fernández C J Oncol Pract; 2017 Jul; 13(7):e613-e622. PubMed ID: 28628392 [TBL] [Abstract][Full Text] [Related]
12. Concomitant drugs with low risks of drug-drug interactions for use in oncology clinical trials. Ranchon F; Vial T; Rioufol C; Hénin E; Falandry C; Freyer G; Trillet-Lenoir V; Le Tourneau C; You B Crit Rev Oncol Hematol; 2015 May; 94(2):189-200. PubMed ID: 25638703 [TBL] [Abstract][Full Text] [Related]
14. Nationwide prevalence of potential drug-drug interactions associated with non-anticancer agents in patients on oral anticancer agents in South Korea. Song YK; Oh JM Support Care Cancer; 2020 Aug; 28(8):3711-3720. PubMed ID: 31820128 [TBL] [Abstract][Full Text] [Related]
15. Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines. Roselló S; Blasco I; García Fabregat L; Cervantes A; Jordan K; Ann Oncol; 2017 Jul; 28(suppl_4):iv100-iv118. PubMed ID: 28881914 [No Abstract] [Full Text] [Related]
17. [Determination of blood levels for oral anticancer drugs]. van Erp NP; van der Graaf WT Ned Tijdschr Geneeskd; 2014; 158():A7884. PubMed ID: 25467023 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study. Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926 [TBL] [Abstract][Full Text] [Related]
19. Risk Factors Associated With Unplanned Acute Care in Outpatient Chemotherapy With Oral Anticancer Drugs as Monotherapy or Combination Therapy With Injectable Anticancer Drugs. Kawasumi K; Kawano Y; Kujirai A; Mano Y; Matsui R; Maeda-Minami A; Yamamoto Y; Negishi K; Shimada S; Yamaguchi M; Nagata M; Aoyama T Anticancer Res; 2021 Nov; 41(11):5827-5834. PubMed ID: 34732458 [TBL] [Abstract][Full Text] [Related]
20. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia. Wong CM; Ko Y; Chan A Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]